rs139722368
Positions:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM4BP6_ModerateBA1
The NM_032776.3(JMJD1C):c.3473_3478delGTTTAG(p.Gly1158_Leu1159del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.0352 in 1,613,900 control chromosomes in the GnomAD database, including 2,327 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.035 ( 277 hom., cov: 32)
Exomes 𝑓: 0.035 ( 2050 hom. )
Consequence
JMJD1C
NM_032776.3 disruptive_inframe_deletion
NM_032776.3 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.51
Genes affected
JMJD1C (HGNC:12313): (jumonji domain containing 1C) The protein encoded by this gene interacts with thyroid hormone receptors and contains a jumonji domain. It is a candidate histone demethylase and is thought to be a coactivator for key transcription factors. It plays a role in the DNA-damage response pathway by demethylating the mediator of DNA damage checkpoint 1 (MDC1) protein, and is required for the survival of acute myeloid leukemia. Mutations in this gene are associated with Rett syndrome and intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_032776.3.
BP6
Variant 10-63208190-ACTAAAC-A is Benign according to our data. Variant chr10-63208190-ACTAAAC-A is described in ClinVar as [Benign]. Clinvar id is 529718.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.249 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JMJD1C | NM_032776.3 | c.3473_3478delGTTTAG | p.Gly1158_Leu1159del | disruptive_inframe_deletion | 10/26 | ENST00000399262.7 | NP_116165.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JMJD1C | ENST00000399262.7 | c.3473_3478delGTTTAG | p.Gly1158_Leu1159del | disruptive_inframe_deletion | 10/26 | 5 | NM_032776.3 | ENSP00000382204.2 | ||
JMJD1C | ENST00000542921.5 | c.2927_2932delGTTTAG | p.Gly976_Leu977del | disruptive_inframe_deletion | 9/25 | 1 | ENSP00000444682.1 | |||
JMJD1C | ENST00000402544.5 | n.3445_3450delGTTTAG | non_coding_transcript_exon_variant | 7/22 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0349 AC: 5305AN: 152184Hom.: 275 Cov.: 32
GnomAD3 genomes
AF:
AC:
5305
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0533 AC: 13273AN: 248954Hom.: 1034 AF XY: 0.0482 AC XY: 6516AN XY: 135062
GnomAD3 exomes
AF:
AC:
13273
AN:
248954
Hom.:
AF XY:
AC XY:
6516
AN XY:
135062
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0353 AC: 51559AN: 1461598Hom.: 2050 AF XY: 0.0340 AC XY: 24705AN XY: 727110
GnomAD4 exome
AF:
AC:
51559
AN:
1461598
Hom.:
AF XY:
AC XY:
24705
AN XY:
727110
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0349 AC: 5308AN: 152302Hom.: 277 Cov.: 32 AF XY: 0.0373 AC XY: 2781AN XY: 74480
GnomAD4 genome
AF:
AC:
5308
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
2781
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
415
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
JMJD1C-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Early myoclonic encephalopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at